Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from Lemaitre Vascular ( (LMAT) ).
LeMaitre Vascular announced the pricing of its $150 million offering of 2.50% Convertible Senior Notes due 2030 to qualified institutional buyers. The notes will accrue interest semi-annually and mature in 2030, with potential conversion into common stock. The proceeds, estimated at $145.9 million, will be used for working capital and potentially for acquisitions or investments in complementary businesses or products.
More about Lemaitre Vascular
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for treating peripheral vascular disease, which affects over 200 million people worldwide. The company develops, manufactures, and markets disposable and implantable vascular devices primarily for vascular surgeons.
YTD Price Performance: 63.56%
Average Trading Volume: 139,520
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $2.07B
For a thorough assessment of LMAT stock, go to TipRanks’ Stock Analysis page.
